MedPath

Evaluating the Safety and Efficacy of LIPO-202 for the Reduction of Central Abdominal Bulging Due to Subcutaneous Fat (AbCONTOUR2)

Phase 3
Completed
Conditions
Central Abdominal Bulging
Interventions
Drug: Placebo
Registration Number
NCT02398188
Lead Sponsor
Evofem Inc.
Brief Summary

This is a multi-center, randomized, double-blinded, placebo-controlled study evaluating the safety and efficacy of LIPO-202 for the reduction of central abdominal bulging due to subcutaneous fat in non-obese subjects.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
793
Inclusion Criteria
  • Healthy male or non-pregnant female subjects
  • Capable of providing written consent.
  • BMI < 30 kg/m2
  • Stable diet and exercise routine
  • Central abdominal bulging that is evaluated by the clinician at least slight bulge, not flat
Exclusion Criteria
  • Have had any treatment of the fat around your abdomen, including surgical procedures (tummy tuck, liposuction), injections for fat loss or treatments with devices to reduce fat in your abdomen.
  • Plan on starting a weight loss or exercise program during the study.
  • Known hypersensitivity to study drugs

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
LIPO-202LIPO-202Experimental arm
PlaceboPlaceboPlacebo comparator
Primary Outcome Measures
NameTimeMethod
Percentage of Subjects Who Achieved a Composite P-GAPS1/CPnS2 ResponseBaseline and End of Study (1 week post last treatment, 9 weeks after first treatment)

The composite P-GAPS1/CPnS2 response was defined as at least a 1 point (grade) improvement in P-GAPS and at least a 2 point (grade) improvement in CPnS from baseline after 8 weeks of treatment.

Patient - Global Abdominal Perception Scale (P-GAPS) - a patient views and assesses the contour of their abdomen on a 5-point verbal scale ranging from "Flat" to "Big Bulge".

Clinician Photonumeric Scale (CPnS) - a trained clinician rater examines the subject's abdomen and matches the subject's abdominal bulge/profile to the nearest gender-specific abdominal photo on the 6-point scale.

Percent Change in the Patient Reported Global Abdominal Perception Score8 weeks post the start of treatment

1 equals much improved, 7 equals much worse. The higher the scores the worse the outcome.

Secondary Outcome Measures
NameTimeMethod
Percent Change in Waist Circumference8 weeks post the start of treatment

Trial Locations

Locations (35)

Society Hill Dermatology

🇺🇸

Philadelphia, Pennsylvania, United States

Wake Research Associates

🇺🇸

Raleigh, North Carolina, United States

Zel Skin & Laser Specialist, LLC

🇺🇸

Edina, Minnesota, United States

SkinCare Physicians

🇺🇸

Chestnut Hill, Massachusetts, United States

Altus Research

🇺🇸

Lake Worth, Florida, United States

Laser and Skin Surgery Center of Indiana

🇺🇸

Carmel, Indiana, United States

Image Dermatology

🇺🇸

Montclair, New Jersey, United States

Rancho Mirage Dermatology

🇺🇸

Rancho Mirage, California, United States

Modern Research Associates, PLLC

🇺🇸

Dallas, Texas, United States

Premier Clinical Research

🇺🇸

Spokane, Washington, United States

DeNova Research

🇺🇸

Chicago, Illinois, United States

Therapeutics Clinical Research

🇺🇸

San Diego, California, United States

The Miami Institute

🇺🇸

Miami, Florida, United States

Suzanne Bruce and Associates, P.A., The Center for Skin Research

🇺🇸

Houston, Texas, United States

Ablon Skin Institute And Research Center

🇺🇸

Manhattan Beach, California, United States

Dermatology Specialists, Inc.

🇺🇸

Oceanside, California, United States

Diagnamics, Inc.

🇺🇸

Encinitas, California, United States

Faces Plus

🇺🇸

San Diego, California, United States

Syrentis Clinical Research

🇺🇸

Santa Ana, California, United States

Baumann Cosmetic and Research Institute

🇺🇸

Miami, Florida, United States

Miami Research Associates

🇺🇸

South Miami, Florida, United States

South Bend Clinic

🇺🇸

South Bend, Indiana, United States

Sadick Research Group

🇺🇸

New York, New York, United States

Paddington Testing Co., Inc.

🇺🇸

Philadelphia, Pennsylvania, United States

Chaddsford Dermatology

🇺🇸

Chadds Ford, Pennsylvania, United States

Austin Institute Clinical Research

🇺🇸

Pflugerville, Texas, United States

Stoll Dermatology of Beverly Hills

🇺🇸

Beverly Hills, California, United States

Mercy Health Research

🇺🇸

Washington, Missouri, United States

Total Skin and Beauty Dermatology Center

🇺🇸

Birmingham, Alabama, United States

Colorado Medical Research Center

🇺🇸

Denver, Colorado, United States

The Savin Center, PC

🇺🇸

New Haven, Connecticut, United States

Clinical Research of West Florida, Inc.

🇺🇸

Tampa, Florida, United States

Oregon Medical Research Center

🇺🇸

Portland, Oregon, United States

Tennessee Clinical Research Center

🇺🇸

Nashville, Tennessee, United States

DermResearch Inc.

🇺🇸

Austin, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath